Evidence map›Paper›PMID 40776813›Full record

ReviewMolecular nutrition & food research2025

Impact of Nutrition on Sphingolipid-Regulated Physiology: A Review.

Jonas Voß, Thorsten Hornemann, Bengt-Frederik Belgardt

Abstract readReview
In one paragraph

Review in Molecular nutrition & food research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Sphingolipids in Emotional Well-Being.Journal of neurochemistry · 2026
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jonas VoßInstitute for Vascular and Islet Cell Biology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.ORCID 0009-0000-4079-0148
Thorsten HornemannInstitute for Clinical Chemistry, Zürich, Switzerland.ORCID 0000-0002-4218-1087
Bengt-Frederik BelgardtInstitute for Vascular and Islet Cell Biology, German Diabetes Center (DDZ), Leibniz Center for Diabetes Research at Heinrich Heine University Düsseldorf, Düsseldorf, Germany.ORCID 0000-0003-4537-9002

Funding

Federal Ministry of Education and Research (BMBF)German Center for Diabetes Research (DZD e.V.)German Federal Ministry of Health (BMG)Ministry of Culture and Science of the State of North Rhine-Westfalia (MKW NRW)
6 · The paper itself

Abstract

Sphingolipids (SLs) are a very diverse group of lipids already described by German physician Johann Thudichum in 1884. The name of these lipids originates from their (at the time) enigmatic nature and lack of knowledge about their cellular function, which was compared to the creature sphinx in Greek mythology. Today we know that SLs play an important role in a plethora of physiological and cellular processes, including tissue development, growth regulation, apoptosis, adhesion, cell migration, cell senescence, receptor signaling, and hormonal effects and are associated with multiple pathological processes in many different disease contexts. In addition to roles for specific SLs in developmental processes, their critical role in causing and preventing metabolic diseases, including cardiovascular disease, obesity, and diabetes during adulthood, has been uncovered through targeted genetic manipulation, lipidomics, and advanced biochemical analyses such as lipid-protein interactomics. Notably, in the context of maternal and paternal effects on offspring and their risk for metabolic disease, there is a gap in our knowledge regarding SLs in transgenerational disease mechanisms. This review summarizes our knowledge on SL metabolism and cellular roles in health and disease, while focusing on the current knowledge of dietary effects on SL-controlled metabolism of adults and their developing offspring.

Indexed as

SphingolipidsAnimalsDietHumansMetabolic DiseasesSphingolipidsceramidemetabolic diseasenutritionobesitysphingolipidType 2 diabetes

Identifiers

PMID40776813
PMCPMC12538533

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.